GREY: PDE5 inhibitors are generally considered equivalent. 2nd line choice for patients intolerant to sildenafil (1st line) should be based on cost (decision date - May 2014)
GREY:5 Orodispersible - should be reserved for those with true dysphagia with choice based on cost (decision date - March 2012)